{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:11:20Z","timestamp":1790928680008,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Indonesian Endowment Fund for Education (Lembaga Pengelola Dana Pendidikan \/ LPDP) scholarship"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jpba.2020.113429","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T11:41:35Z","timestamp":1592394095000},"page":"113429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["A sensitive HPLC-UV method for quantifying vancomycin in biological matrices: Application to pharmacokinetic and biodistribution studies in rat plasma, skin and lymph nodes"],"prefix":"10.1016","volume":"189","author":[{"given":"Delly","family":"Ramadon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Courtenay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andi Dian","family":"Permana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismaiel A.","family":"Tekko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"McAlister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mael\u00edosa T.C.","family":"McCrudden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan F.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113429_bib0005","first-page":"1","article-title":"Review on usage of vancomycin in livestock and humans: maintaining its efficacy, prevention of resistance and alternative therapy","volume":"4","author":"Wijesekara","year":"2017","journal-title":"Vet. Sci."},{"key":"10.1016\/j.jpba.2020.113429_bib0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The nephrotoxicity of vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2020.113429_bib0015","first-page":"1249","article-title":"Section 7: anti-infective therapy 145","author":"Parente","year":"2017","journal-title":"Infect. Dis. Auckland"},{"key":"10.1016\/j.jpba.2020.113429_bib0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jiac.2018.10.013","article-title":"Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid\/serum albumin ratio","volume":"25","author":"Ishikawa","year":"2019","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jpba.2020.113429_bib0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000334706","article-title":"Determination of residual antibiotics in cryopreserved heart valve allografts","volume":"38","author":"Jashari","year":"2011","journal-title":"Transfus. Med. Hemother."},{"key":"10.1016\/j.jpba.2020.113429_bib0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jpba.2008.05.040","article-title":"Development and validation of an HPLC method for vancomycin and its application to a pharmacokinetic study","volume":"48","author":"Valle","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113429_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7150\/ijms.13601","article-title":"Therapeutic drug monitoring of vancomycin in dermal interstitial fluid using dissolving microneedles","volume":"13","author":"Ito","year":"2016","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.jpba.2020.113429_bib0040","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1590\/S0100-40422007000200029","article-title":"Analytical methods for vancomycin determination in biological fluids and in pharmaceuticals","volume":"30","author":"Vila","year":"2007","journal-title":"Quim. Nova"},{"key":"10.1016\/j.jpba.2020.113429_bib0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpba.2018.12.023","article-title":"Simultaneous determination of vancomycin and creatinine in plasma applied to volumetric absorptive microsampling devices using liquid chromatography-tandem mass spectrometry","volume":"165","author":"Andriguetti","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113429_bib0050","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1373\/clinchem.2011.167189","article-title":"Liquid chromatography-Tandem mass spectrometry or auomated immunoassays: what are the future trends in therapeutic drug monitoring?","volume":"58","author":"Brandhorst","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2020.113429_bib0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0378-4347(00)00484-9","article-title":"New sensitive assay of vancomycin in human plasma using high-performance liquid chromatography and electrochemical detection","volume":"751","author":"Favetta","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jpba.2020.113429_bib0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00216-009-2948-9","article-title":"Determination of vancomycin in human plasma using high-performance liquid chromatography with fluorescence detection","volume":"395","author":"Abu-Shandi","year":"2009","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2020.113429_bib0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jpba.2019.05.056","article-title":"A rapid and simple UPLC method for serum vancomycin determination in pediatric patients undergoing continuous infusion or intermittent infusion of vancomycin","volume":"174","author":"Zhang","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113429_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40064-016-1778-4","article-title":"Development and validation of an HPLC method for the determination of vancomycin in human plasma and its comparison with an immunoassay (PETINIA)","volume":"5","author":"Usman","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.jpba.2020.113429_bib0075","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1016\/j.bmc.2016.11.008","article-title":"Animal models in the pharmacokinetic \/ pharmacodynamic evaluation of antimicrobial agents","volume":"24","author":"Zhao","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jpba.2020.113429_bib0080","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.anai.2019.09.002","article-title":"Vancomycin-induced DRESS syndrome","volume":"124","author":"Zafar","year":"2020","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.jpba.2020.113429_bib0085","series-title":"Guideline on Bioanalytical Method Validation","year":"2011"},{"key":"10.1016\/j.jpba.2020.113429_bib0090","series-title":"Center for Drug Evaluation and Research, Guidance for Industry: Bioanalytical Methods Validation. USA","author":"Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.jpba.2020.113429_bib0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpba.2019.03.047","article-title":"New HPLC\u2013MS method for rapid and simultaneous quantification of doxycycline, diethylcarbamazine and albendazole metabolites in rat plasma and organs after concomitant oral administration","volume":"170","author":"Permana","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113429_bib0100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejps.2018.05.009","article-title":"Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery","volume":"121","author":"Pamornpathomkul","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2020.113429_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jpba.2017.04.029","article-title":"Simple and rapid quantification of vancomycin in serum, urine and peritoneal\/pleural effusion via UHPLC\u2013MS\/MS applicable to personalized antibiotic dosing research","volume":"142","author":"Javorska","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113429_bib0110","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/chromsci\/bmy060","article-title":"A LC-MS-MS assay for simultaneous determination of two glycopeptides and two small molecule compounds in human plasma","volume":"56","author":"Shi","year":"2018","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2020.113429_bib0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/AAC.00636-08","article-title":"Microanalysis of \u03b2-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates","volume":"53","author":"Ahsman","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2020.113429_bib0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.xphs.2017.09.003","article-title":"Effect of water on the chemical stability of amorphous pharmaceuticals: 2. Deamidation of peptides and proteins","volume":"107","author":"Ohtake","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2020.113429_bib0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0731-7085(98)00095-8","article-title":"A modified HPLC method for the determination of vancomycin in plasma and tissues and comparison to FPIA (TDX)","volume":"18","author":"Farin","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113429_bib0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40121-019-00268-3","article-title":"Relationship status between vancomycin loading dose and treatment failure in patients with MRSA bacteremia: it\u2019s complicated","volume":"8","author":"Ortwine","year":"2019","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.jpba.2020.113429_bib0135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/10717549709051888","article-title":"Pharmacokinetics of vancomycin after intravenous administration of a W\/O\/W emulsion to rats","volume":"4","author":"Okochi","year":"1997","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jpba.2020.113429_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02123-w","article-title":"Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria","volume":"9","author":"Blaskovich","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpba.2020.113429_bib0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1570-0232(03)00068-0","article-title":"Highly sensitive quantification of vancomycin in plasma samples using liquid chromatography\u2013tandem mass spectrometry and oral bioavailability in rats","volume":"789","author":"Shibata","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2020.113429_bib0150","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jiac.2017.08.004","article-title":"An extremely high bioavailability of orally administered vancomycin in a patient with severe colitis and renal insufficiency","volume":"23","author":"Yamazaki","year":"2017","journal-title":"J. Infect. Chemother."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520313157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520313157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:03:52Z","timestamp":1760000632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708520313157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"alternative-id":["S0731708520313157"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113429","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A sensitive HPLC-UV method for quantifying vancomycin in biological matrices: Application to pharmacokinetic and biodistribution studies in rat plasma, skin and lymph nodes","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113429"}}